Viridian Therapeutics, Inc.

VRDN ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Jan 20, 2021 FORM 4 SUBMISSION
4 Jan 20, 2021 FORM 4 SUBMISSION
8-K Jan 20, 2021 8-K
4 Jan 19, 2021 FORM 4 SUBMISSION
4 Jan 19, 2021 FORM 4 SUBMISSION
SC 13G Jan 19, 2021
4 Jan 15, 2021 FORM 4 SUBMISSION
SC 13G Jan 11, 2021 SC 13G
SC 13G Jan 11, 2021 SC 13G
SC 13G Jan 7, 2021 SC 13G
SC 13D Jan 5, 2021 SC 13D
8-K Jan 4, 2021 8-K
424B5 Dec 23, 2020 424B5
EFFECT Dec 22, 2020
UPLOAD Dec 21, 2020
CORRESP Dec 21, 2020
UPLOAD Dec 18, 2020
SC 13G Dec 17, 2020 SCHEDULE 13G
3 Dec 17, 2020 OWNERSHIP DOCUMENT
8-K Dec 17, 2020 8-K
S-3 Dec 15, 2020 S-3
DEF 14A Dec 14, 2020 DEF 14A
424B5 Dec 11, 2020 424B5
8-K Dec 9, 2020 8-K
CORRESP Dec 8, 2020
← Newer Page 16 of 33 · 819 filings Older →